Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001060793 | SCV001225504 | uncertain significance | Charcot-Marie-Tooth disease, type I | 2019-01-30 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with glutamic acid at codon 136 of the MPZ protein (p.Val136Glu). The valine residue is highly conserved and there is a moderate physicochemical difference between valine and glutamic acid. This variant is not present in population databases (ExAC no frequency). This variant has been observed in a family affected with Charcot-Marie-Tooth disease (PMID: 11835375). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Inherited Neuropathy Consortium | RCV000790054 | SCV000929444 | uncertain significance | Dejerine-Sottas disease | no assertion criteria provided | literature only |